Диссертация (1146697), страница 19
Текст из файла (страница 19)
- № 2. – С. 292.69.ХасановаС.И.формированииклапана сердца /Рольсоединительнотканнойсклеро-дегенеративныхдисплазиипораженийваортальногоС.И. Хасанова // Дисс… канд. мед. наук. – СПб. –2010. – 162с.70.Черноруцкий М.В. Наше понимание конституции // Врачебнаягазета. – 1929. - №6. – С. 355-356.71.Щепин О.П. Пути решения проблем здравоохранения / О.П. Щепин,В.К. Овчаров // Проблемы соц. гигиены, здравоохранения и историимедицины.
– 2004. - №1. – С. 3-6.72.Щеплягина Л.А. Проблемы остеопороза в педиатрии: научные ипрактические задачи / Л.А. Щеплягина, Т.Ю. Моисеева //Российский педиатрический журнал. – 2004. – Т. 8. - № 1. – С. 4-11.73.Ягода А.В. Малые аномалии сердца / А.В. Ягода, Н.Н. Гладких //Ставрополь. – Изд. СтГМА. – 2005. – 248 с.74.Яковлев В.М. Классификационная концепция наследственнойдисплазии соединительной ткани / В.М.
Яковлев, Г.И. Нечаева //Омский научный вестник. – 2001. – С.68-70.75.Adams J.E. Quantitative Computed Tomography / J.E. Adams // Eur JRadiol. – 2009. – 71. – Р. 415-424.76.Alliston T. TGF- regulation of osteoblast differentiation and bone matrixproperties / T. Alliston // J Musculoskelet Neuronal Interact. – 2006. – 6(4). – Р. 349-350.13077.de Araújo A.M. Study of bone markers in patients with Marfan'ssyndrome / A.M.
de Araújo,C. L.Simplício, M. Ramos, J. Rogério [etal]. // Rev. bras. Ortop. – 2003– 38 (8). – Р. 473-479.78.Agg B. Possible extracardiac predictors of aortic dissection in Marfansyndrome / B. Agg, K. Benke, B. Szilveszter, M. Pólos, L. [et al.] // BMCCardiovasc. Disord. – 2014. – Apr. 11. – P. 14-47.79.Andrew T. Risk of wrist fracture in women is heritable and is influencedby genes that are largely independent of those influencing / T.
Andrew,L. Antioniades, K.J. Scurrah, A.J. Macgregor, T.D. Spector / BMD JBone Miner Res. – 2005. - №20. – Р.67-74.80. Armour K.E. (1999) Evidence for a pathogenic role of nitric oxide ininflammation induced osteoporosis / K.E. Armour, R.J. Van't Hof,P.S. Grabowski, D.M. Reid, S.H. Ralston // Journal of Bone and MineralResearch. – 1999. – 14.
– Р. 2137-2142.81.Baujat G. Osteogenesisimperfecta, diagnosis information (clinical andgenetic classification) / G. Вaujat, A.S. Lebre, V. Cormier-Daire,M. LeMerrer // ArchPediatr. – 2008. – Vol. 15 (5). – P. 789-791.82.Beighton P. Ehlers-Danlos syndromes: Revised nosology, Villefranche /P. Beighton, A.
De Paepe, B. Steinmann, P. Tsipouras, R.J. Wenstrup //Am J of Med Gen. – 1998. – 77 (1). – Р. 31-37.83.Blanchard F. Report on osteoporosis in the European Community:Building Strong Bones and Preventing Fractures. Action for prevention /F. Blanchard // EurCommun Brussels. – 1998. – EC. (Report CE-09-97915-EN-C).84.Bondestam J. Bone biopsy and densitometry findings in a child withCamurati-Engelmann disease / J. Bondestam, M.K. Mäyränpää, S.Ikegawa, E. Marttinen [et al.] // ClinRheumatol. – 2007. – 26.
– Р. 1773–7.85.Bonow R.O. ACC/AHA 2006 Guidelines Update for the Diagnosis andManagement of Chronic Heart A Report of the American College of131Cardiology/American Heart Association Task Force on PracticeGuidelines (Writing Committee to Revise the 1998 Guidelines for theManagement of Patients Wich Valvular Heart Disease ) // Circulation.
–2006. – Aug. 1. – P.148.86.Bowden S.A. Prevalence of vitamin D deficiency and insufficiency inchildren with osteopenia or osteoporosis referred to a pediatric metabolicbone clinic / S.A. Bowden, R.F. Robinson, R. Carr, J.D. Mahan //Pediatrics. – 2008. – Vol. 121. - № 6. – P. e1585-e1590.87.Braunwald´s Heart Disease / P.
Libby, R. Bonow, D. Zipes // A textbookof cardiovascular medicine. W.B. Saunders Company. – 8th edition. –2008. – 2297 p.88.Branco J.C. Epidemiology of osteoporosis in an Inland district ofPortugal / J.C. Branco, A. Briosa, V. Tavares, B. Arriano // OsteoporosisInt. – 1996.– Р. 6-9.89.Brown J.E. Bone turnover markers as predictors of skeletal complicationsin prostate cancer, lung cancer, and other solid tumors / J.E. Brown,R.E. Coleman // J. Natl.
Cancer Inst. – 2005. – 97 (1). – P. 59-69.90.Cano A. The transcription factor snail controls epithelial-mesenchymaltransitions by repressing E-cadherin expression / A. Cano, M.A. PérezMoreno, I. Rodrigo, A. Locascio [et al.] // Nat Cell Biol. – 2000. – Feb. –2(2). – Р. 76-83.91.Carter N. Bone mineral density in adults with Marfan syndrome / N.Carter, E. Duncan, P. Wordsworth // Rheumatology (Oxford). – 2000. –Mar.
– 39 (3). – Р. 307-9.92.Centrella M. Transforming growth factor β is a bifunctional regulator ofreplication and collagen synthesis in osteoblast-enriched cell culturesfrom fetal rat bone / M. Centrella, T.L. Mccarthy, E. Canalis // J. Biol.Chem. – 1987. – 262. – Р. 2869-2874.93.Carrascosa A. Skeletal mineralization during infancy, childhood andadolescence in the normal population and in populations with nutritional132and hormonal disorders. Dual X-ray absorptiometry (DEXA) evaluation.In: Schönau E, editor.
Paediatric Osteology. New developments indiagnosis and therapy / A. Carrascosa, M. Gussinyé, D. Yeste, L. del Rio[et al.] // Amsterdam: Elsevier Science. – 1996. – P. 93-102.94. Cooper C. Childhood growth, physical activity, and peak bone mass inwomen / C. Cooper, M. Cawley, A. Bhalla, P. Egger et al. // J BoneMiner Res. – 1995. – 10. – P. 940-947.95.D'Amore M. Osteoporosis in adult with Marfan syndrome: casuality orcausality? / M.
D'Amore, G. Minenna, P. Scagliusi, S. D'Amore //Reumatismo. – 2005. – Apr-Jun. – 57 (2). – P.125-7.96.Dempster D.W. Dynamics ofbone and catilage metabolism: principlesand clinical applications / D.W. Dempster // Аcademic Press. San Diego,California, USA. – 1999. – P. 261-273.97.Dennison E.M. Osteoporosis in 2010: building bones and (safely)preventing breaks / E.M. Dennison // Nat. Rev. Rheumatol. – 2011. –Vol.7. - № 1. – Р. 80-82.98.Dent C.E.
Clinical aspects of metabolic bone disease / C.E. Dent //Amsterdam. – 1973. – P. 60.99.De Paepe A. Revised diagnostic criteria for the Marfan syndrome / A. DePaepe, R.B. Devereux, H.C. Dietz [et al.] // Am. J. Med. Genet. – 1996. –Vol. 62. – № 4. – Р. 417-426.100.Dietz H.C. Mutations in the human gene for fibrillin-1 (FBN1) inthe Marfan syndrome and related disorders / H.C. Dietz, R.E. Pyeritz //Hum Mol Genet. – 1995.
– 4. – Р. 1799-1809.101.Dolan A.L. Assessment of bone in Ehlers Danlos syndrome byultrasound and densitometry / A.L. Dolan, N.K. Arden, R. Grahame [etal.] // Ann Rheum Dis. – 1998. – 57. – Р. 630-633.102.Erlenbacher A. Toward a molecular understanding of skeletaldevelopment / A. Erlenbacher, E.H. Filvaroff, S.E. Gitelman, R. Derynck// Cell. – 1995. – 80.
Р. 371-8133103.Edelson G.W. Тhe use of bone markers in osteoporosis /G.W. Edelson, M. Kleerekoper // Journal of clinical ligand assay. 1998 –21 (2). – Р. 96-101.104.Edwards B.J. Functional decline after incident wrist fractures –Study of Osteoporotic Fractures: Prospective cohort study / B.J. Edwards// BMJ. – 2010– 7. – P.
570-580.105.Ehnert S. TGF-b1 as possible link between loss of bone mineraldensity and chronic inflammation / S. Ehnert, J. Baur, A. Schmitt, M.Neumaier, M. Lucke [et al.] // PLoS ONE. – 2010. – 5 (11). – Р. e14073.106.Fedarko N.S. Extracellular matrix formation by osteoblasts frompatients with osteogenesis imperfect / N.S. Fedarko, M. Mörike, R.E.Brenner, G.B. Bushart [et al.] // Biochem J. – 1992. – Aug. 15. – 286.
–Pt. 1. – P. 73-79.107.Fedarko N.S. Collagen metabolism in cultured osteoblasts fromosteogenesisimperfecta patients / N.S. Fedarko // J Bone Miner Res. –1992. - №7 (8) – Р. 921.108.Flicker L. (1996) Determinants of hip axis length in women aged10–89 years: A twin study / L. Flicker, K.G. Faulkner, J.L. Hopper, R.M.Green [et al.] // Bone.
– 1996. – 18. – P. 41-45.109.Franken R. The revised role of TGF-β in aortic aneurysms inMarfan syndrome / R. Franken, T. Radonic, A.W. den Hartog, M.Groenink [et al.] // Neth Heart J. – 2015. – Feb. – 23 (2). – P. 116-21.110.Garnero P. Comparison of new biochemical markers of boneturnover in late postmenopausal osteoporotic women in response toalendronate treatment / P. Garnero, W.J. Shih, E.
Gineyts, D.B. Karpf,P.D. Delmas // J Clin Endocrinol Metab. – 1994. – 79. – P. 1693-1700.111.Galicka A. Comparative studies of osteoblast and fibroblast type Icollagen in a patient with osteogenesisimperfecta type IV / A. Galicka, S.Wolczynski, A. Gindzienski // J Pathol. – 2002. – 196. – P. 235-7.134112.Gennari L. Osteoporosis in men / L.
Gennari, J.P. Bilezikian //Endocrinol Metab Clin North Am. – 2007. – 36. – P. 399-419.113.Giampietro P.F. Assessment of bone mineral density in adults andchildren with Marfan syndrome / P.F. Giampietro, M. Peterson,R. Schneider, J.G. Davis [et al.] // Osteoporos Int. – 2003. - № 14. – Р.559-63.114.Glesby M.J. Association and systemic Abnormalities of ConnectiveTissue / M.J. Glesby, R.E. Pyeritz // J.A.M.A.
– 1989. – V. 262. – P. 523528.115.Greer F.R. Optimizing bone health and calcium intakes of infants,children and adolescents / F.R. Greer, N.F. Krebs // Pediatrics. – 2006. –117. – P. 578-585.116.Gray J.R. Osteoporosis and the Marfan syndrome / J.R.
Gray,A.B. Bridges, P.A. Mole, T. Pringle [et al.] // Postgrad Med J. – 1993. –69. – P. 373-5.117.Greenspan S.L. Early changes in biochemical markers of boneturnover predict the long-term response to alendronate therapy inrepresentative elderly women: a randomized clinical trial / S.L.Greenspan, R.A. Parker, L. Ferguson, H.N. Rosen [et al.] // J Bone MinerRes. – 1998. – Sep.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
